Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Bayer Aktiengesellschaft American Depositary Shares (OP: BAYRY)
108.30 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Bayer Aktiengesellschaft American Depositary Shares
 
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Regeneron in play ahead of FDA meeting
June 15, 2011
Shares of Regeneron are on the move ahead of a key regulatory meeting for its eye drug VEGF Trap-Eye, which, if approved, would compete against Roche and Novartis’ blockbuster therapy Lucentis. Read More
category Aerospace , RHHBY , REGN , and 11 more.
from MarketWatch
Risk-Reward Balanced At Bayer
June 13, 2011
We are maintaining our Neutral recommendation on Germany’s Bayer (BAYRY) with a target price of $86.00. Headquartered in Leverkusen, Bayer is one of the world’s largest healthcare and chemical... Read More
category jnj , Stocks , External Research , and 2 more.
from DailyMarkets.com
Sigma Partners With Ilika
June 13, 2011
Aldrich Materials Science, part of  Sigma-Aldrich Corporation (NASDAQ:SIAL), has signed an agreement to collaborate on the scale-up and commercialization of hydrogen storage materials with Ilika plc,... Read More
category SIAL , Stocks , External Research , and 2 more.
from DailyMarkets.com
Bayer Seeks European Approval
June 10, 2011
Germany’s Bayer (BAYRY) recently submitted an application with the European regulatory body seeking approval for marketing its VEGF (vascular endothelial growth factor) trap-eye treatment in the... Read More
category NVS , REGN , Stocks , and 3 more.
from DailyMarkets.com
Bayer Sexual Discrimination: Stop the Mommy Wars
June 10, 2011
Why can women not call a truce on the mommy wars? We all make choices, and we need to learn to accept the consequences of those choices. Read More
category Suzanne Lucas , Gender And Diversity , bayr y , and 4 more.
from More from Leadership - CBS News
Regeneron Keep
June 09, 2011
We are maintaining our Neutral recommendation on Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) with a target price of $59.00. Regeneron, a biopharmaceutical company, focuses on the discovery,... Read More
category NVS , REGN , SNY , and 4 more.
from DailyMarkets.com
ASCO studies move Exelixis, Sunesis, Oxigene
June 07, 2011
Shares of Exelixis, Sunesis, and Oxigene are moving on presentations made on their respective cancer drugs at the annual meeting of the American Society of Clinical Oncology, or ASCO. Read More
category Market News , REGN , DRG , and 12 more.
from MarketWatch
BioSante, Optimer boost drug stocks
May 31, 2011
Both stocks gain on positive updates for their respective drug-development programs. Read More
category Computer Software , Biotechnology , Analyst , and 24 more.
from MarketWatch
Promising J&J Pharma Pipeline
May 27, 2011
Johnson & Johnson (NYSE:JNJ) recently provided an update on its Pharmaceuticals business. Since its last Pharmaceuticals business review in 2009, the company gained approval for six new drugs and has... Read More
category jnj , ALKS , Stocks , and 4 more.
from DailyMarkets.com
Stocks to watch in the MS drug market
May 26, 2011
A new generation of pills to treat multiple sclerosis is making its way to market, which could be a boon for investors in drug makers like Biogen Idec and Teva. Read More
category Computer Software , Biotechnology , Retail , and 25 more.
from MarketWatch
Bayer CropScience Begins Corn and Soybean Greenhouse Construction, Prepares to House Biodiesel Plant
May 26, 2011
SUGAR LAND--May 26, 2011--Researched by Industrial Info Resources (Sugar Land, Texas)-- Bayer AG (PINK:BAYRY) (Leverkusen, Germany) and Bayer CropScience LP (Durham, North Carolina) have begun... Read More
from IIR Industry News Alerts
May 26, 2011 - Today's Industrial Market News from Industrialinfo.com
May 26, 2011
Companies featured in this segment: Amazon.com Incorporated (NASDAQ:AMZN), Bayer AG (PINK:BAYRY) Read More
from Industrial Info Daily News Podcast
May 26, 2011 - Today's Industrial Market News from Industrialinfo.com
May 26, 2011
Companies featured in this segment: Amazon.com Incorporated (NASDAQ:AMZN), Bayer AG (PINK:BAYRY) Read More
from Industrial Info Daily News Podcast
Ardea Biosciences Evenly Poised
May 25, 2011
We are maintaining our Neutral recommendation on Ardea Biosciences Inc. (NASDAQ:RDEA) with a target price of $24.00. Ardea Biosciences, headquartered in San Diego, California, focuses on the discovery... Read More
category RDEA , Stocks , External Research , and 2 more.
from DailyMarkets.com
FDA To Review REGN Eye Drug
May 24, 2011
Recently, the US Food and Drug Administration (FDA) announced that its Dermatologic and Ophthalmic Advisory Committee will meet on June 17, 2011 to review the biologics license application (BLA)... Read More
category NVS , REGN , Stocks , and 3 more.
from DailyMarkets.com
Sigma-Aldrich Acquires Vetec
May 24, 2011
Biotechnology giant Sigma-Aldrich Corporation (NASDAQ:SIAL) has acquired all outstanding shares of Vetec Quimica Fina Ltda. essentially to fortify the company’s position in Latin America. Terms of the... Read More
category SIAL , Stocks , External Research , and 2 more.
from DailyMarkets.com
Europe’s sovereign-debt crisis Effects on Drug Stocks
May 23, 2011
Italy sovereign-debt crisis news, Standard & Poor’s Ratings late last week lowered its outlook on Italy’s A-plus sovereign-credit rating from stable to negative- Drug stocks dipped. Johnson & Johnson... Read More
category Johnson & Johnson , Bayer AG , Parexel International , and 17 more.
from CEOWORLD Magazine
Big Pharma follows broader market south
May 23, 2011
Shares of the major drug makers fall in morning action as the broader market loses ground over renewed fears about the extent of the European debt crisis. Read More
category Biotechnology , Retail , Analyst , and 24 more.
from MarketWatch
Onyx leads declines in biotech stocks
May 19, 2011
Shares of Onyx Pharmaceuticals are falling after it released data from a Phase II study for its drug Nexavar in the treatment of breast cancer. Read More
category Market News , DRG , Biotechnology , and 11 more.
from MarketWatch
Optimer Beats On One-Time Gain
May 10, 2011
Optimer Pharma’s (NASDAQ:OPTR) first quarter 2011 earnings of $1.14 per share tellingly reversed the year-ago loss of 39 cents per share and exceeded the Zacks Consensus Estimate of 30 cents. The... Read More
category RHHBY , OPTR , External Research , and 11 more.
from DailyMarkets.com
International drug makers lead pharma stocks lower
May 05, 2011
Multinational drug makers dragged biotech stocks south as a series of lackluster earnings burdened sentiment. Read More
category Earnings , Biotechnology , BAYRY , and 15 more.
from MarketWatch
Higher-than-Expected Loss At Onyx
May 05, 2011
Onyx Pharmaceuticals Inc.’s (NASDAQ:ONXX) first quarter 2011 loss of 31 cents per share was a couple of cents wider than the Zacks Consensus Estimate and 21 cents wider than the year-ago loss. Despite... Read More
category ONXX , Eurozone , CELG , and 5 more.
from DailyMarkets.com
Agri-Tech Heats Up (MOO, ZBRA, IBM, QGEN, DOW)
May 04, 2011
Just as technology has revolutionized the healthcare industry, agriculture is undergoing its own tech renaissance. Read More
from Investopedia Advisor Commentary
Strong Quarter At Bayer, View Upped
May 02, 2011
Bayer’s (BAYRY) earnings per share during the first quarter of 2011 came in at €1.45 (approx $1.99) compared to €1.13 (approx. $1.64) in the year-ago period. Strong revenues boosted earnings. The... Read More
category USA , Stocks , Japan , and 3 more.
from DailyMarkets.com
Canaccord Genuity Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); Q1/11 Results Preview; C-mib Data This Week
May 02, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6462698 for the full story. Read More
from StreetInsider.com News Articles
Watson Beats On EPS; Ups Guidance
April 27, 2011
Watson Pharmaceuticals Inc.’s  (NYSE:WPI) first quarter 2011 earnings (excluding special items) of 89 cents per share beat the Zacks Consensus Estimate by 3 cents and the year-ago earnings by 8 cents.... Read More
category Australia , External Research , Contributor , and 7 more.
from DailyMarkets.com
Sigma Surpasses Estimates
April 26, 2011
Sigma-Aldrich Corporation (NASDAQ:SIAL) delivered first quarter earnings of 97 cents, which surpassed both the Zacks Consensus Estimate of 89 cents and prior-year earnings per share (EPS) of 81 cents.... Read More
category USA , SIAL , Stocks , and 3 more.
from DailyMarkets.com
European drug makers rally in early action
April 20, 2011
Among U.S. companies in the sector, Johnson & Johnson leads gains for large caps. Read More
category Earnings , Biotechnology , Company Announcements/Warnings , and 20 more.
from MarketWatch
Zacks Bull and Bear of the Day Highlights: Tesoro, Campbell Soup, Merck & Co, Bayer and Bristol-Myers
April 14, 2011
from PR Newswire
NVS Amends SNDA; Completes Merger
April 11, 2011
Novartis (NYSE:NVS) recently announced amendment to its supplemental new drug application (sNDA) for Afinitor tablets. Afinitor is currently marketed for the treatment of advanced renal cell carcinoma... Read More
category External Research , Contributor , BAYRY , and 6 more.
from DailyMarkets.com
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here